CE Tracking
Digital continuing education tracking for staff credentialing
Software · Cloud SaaSCompany source
Company profile
About Densitas
Densitas is a global leader in artificial intelligence solutions for breast cancer screening and mammography quality improvement. The company's flagship intelliMammo platform delivers comprehensive AI-powered tools that address the most pressing challenges facing breast imaging providers today. The platform automates mammography positioning assessment, breast density evaluation, MQSA EQUIP compliance reporting, equipment quality control, and continuing education tracking. By streamlining routine tasks and providing actionable analytics, Densitas enables technologists and radiologists to focus on complex cases while reducing burnout and improving operational efficiency. The intelliMammo platform provides standardized, reproducible breast density assessments aligned with ACR 5th edition guidance, automated positioning quality review with advanced analytics for benchmarking and trend detection, and comprehensive quality metrics that support real-time technique coaching. Densitas serves health systems, imaging centers, and radiology practices globally, with solutions trusted by leading healthcare organizations. The company's evidence-based approach combines rigorous scientific validation across multi-site, multi-vendor datasets with real-world clinical usability. Through strategic partnerships with major imaging technology providers and integration into existing PACS and workflow systems, Densitas delivers vendor-neutral solutions that fit seamlessly into clinical operations while elevating mammography quality standards and patient care outcomes.
Company description Densitas official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Densitas?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Breast cancer screening
- High-risk breast cancer management
- Mammography quality improvement
Who it serves
- Academic Medical Centers
- Breast Imaging Facilities
- Health Systems
- Imaging Centers
- Radiology Practices
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: AGFA HealthCare, Blackford Analysis Platform, iCAD ProFound, Ikonopedia, Intelerad, Nuance AI Marketplace, ScreenPoint Medical Transpara, WorkstationOne.
Geographic context
MarketsCanada · Global (50+ countries mentioned for partner iCAD) · UK · USA
Company sourceOfficial website
Company milestones
Platform expansion
ACR Learning Network Vendor Partner designation (October 2025); Mount Sinai ACR ImPower collaboration results published (October 2025); MAMMO.IQ multicenter study results published in Journal of Breast Imaging (July 2025); TungstenQI strategic partnership launched (April 2025)
Partnerships
Recorded partners
- American College of Radiology (ACR)
- Blackford Analysis
- iCAD
- Intelerad
- Mammography Educators
- Medical Technology Management Institute (MTMI)
- Mount Sinai Health System
- Nova Scotia Health
- Nuance
- Ottawa Hospital
- RAD-AID International
- ScreenPoint Medical
- TungstenQI Partners
- University Radiology Group
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
densityAI
Automated standardized breast density assessment aligned with ACR guidance
Software · Cloud SaaSCompany source
Equipment QC
Digital equipment quality control with remote oversight capabilities
Software · Cloud SaaSCompany source
intelliMammo Platform
AI-powered mammography quality improvement and workflow automation platform
Platform · Cloud SaaSCompany source
intelliMammo Quality Improvement
Automated mammography positioning and image quality assessment
Software · Cloud SaaSCompany source
intelliRisk
Scalable high-risk breast cancer management and risk assessment
Software · Cloud SaaSCompany source
Positioning Analytics
Advanced analytics for mammography positioning quality tracking
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
densitas densityaiK192973 · 510k · Feb 19, 2020
DM-DensityK170540 · 510k · Feb 23, 2018
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
33% increase in mammography positioning quality
Mount Sinai collaboration with ACR ImPower Program
Reduced inter-technologist variability
Standardized positioning criteria implementation
Minutes instead of days for EQUIP report generation
Automated compliance reporting
Mount Sinai Health System
Mammography positioning quality improvement through ACR ImPower Program
33% increase in mammography positioning quality, reduced inter-technologist variability, and established foundation for sustained automated quality tracking
Nova Scotia Health (NSH)
Standardized breast density reporting across health system
Rapid, reproducible, and standardized density reporting ensuring consistent results across different clinics and radiologists
Ottawa Hospital
Mammography image quality improvement
Ensured good quality images critical for cancer detection by radiologists
RAD-AID International
Remote mammography quality monitoring and management
Significant improvement in technologists' positioning performance and increased confidence in providing feedback
TeleMammography Specialists
ACR accreditation and MQSA EQUIP compliance preparation
Identified high-quality mammograms in minutes instead of days and automatically generated comprehensive EQUIP reports
University Radiology Group
Workforce optimization and operational efficiency during workforce crisis
Automated image quality and density assessments allowing technologists more time for mammograms and radiologists to focus on interpretation while maintaining exceptional patient care
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Densitas
Recent articles published on Densitas's official website.
Densitas Debuts intelliRisk, a High-Risk Breast Cancer Patient Management Platform
Read on DensitasDensitas Announces the Commercial Release of intelliMaven™: The First GPT AI Companion to Elevate Mammography Quality Standards.
Read on DensitasDensitas: AI Identifies Persistent Mammography Positioning Challenges Impacting Screening Quality and Cancer Detection
Read on DensitasDensitas Announces the Commercial Availability of intelliRisk, a High-Risk Breast Cancer Patient Management Platform
Read on DensitasDensitas / ACR Learning Network Strategic Collaboration to Improve Mammography Positioning
Read on Densitas07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.